相关实验视频
Updated: Jun 17, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
对美国食品和药物管理局 (FDA) 的不良事件报告系统 (FAERS) 事件进行的真实世界药监测研究
Xusheng Zhang1, Xiuli Ren1, Tianyu Zhu2
1Department of Pharmacology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
这项研究分析了35923份关于sunitinib的不良事件报告,证实了已知的副作用,并确定了新的安全信号,如皮膜黑色细胞增殖. 这些发现支持安全的现实世界使用和临床监测sunitinib.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 苏尼提尼布已被批准用于转移性细胞癌 (mRCC),耐伊马替尼布的胃肠道 stromal 瘤 (GIST) 和晚期胰腺神经内分泌瘤 (PNET).
- 调查sunitinib的安全概况对于其实际应用至关重要.
研究的目的:
- 挖掘美国食品和药物管理局不良事件报告系统 (FAERS) 数据库,寻找与sunitinib相关的潜在安全信号.
- 为了确定与sunitinib治疗相关的已知和以前未被识别的不良事件 (AE).
主要方法:
- 从FAERS收集了2006年第一季度到2024年第一季度的sunitinib个别病例安全报告 (ICSR).
- 使用不成比例分析,包括ROR,PRR,BCPNN和MGPS,以检测重要的安全信号.
- 标准化和分析了35,923种ICSR,其中sunitinib是主要的疑似药物.
主要成果:
- 确定了276个与sunitinib相关的不成比例的偏好术语 (PT).
- 常见的副作用 (腹,喘息,食欲下降,高血压,失血症) 与现有数据保持一致.
- 检测到意想不到的安全信号,包括脑膜黑色细胞增殖,唾液腺,皮肤/毛/阴囊变化.
- 副作用的中位发病时间为57天,其中很大一部分发生在治疗的第一个月内.
结论:
- 该研究证实了已知的sunitinib副作用,并确定了新的安全信号.
- 这些发现为sunitinib的安全使用和临床监测提供了有价值的现实世界的证据.
- 这种药监测分析有助于识别sunitinib治疗的风险.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Clinical Trials: Overview
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Clinical Trials
There are four phases in a clinical trial. A phase one...